Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences